| Peginterferon plus adefovir versus either drug alone for hepatitis delta H Wedemeyer, C Yurdaydìn, GN Dalekos, A Erhardt, Y Çakaloğlu, ... New England Journal of Medicine 364 (4), 322-331, 2011 | 564 | 2011 |
| Late HDV RNA relapse after peginterferon alpha‐based therapy of chronic hepatitis delta B Heidrich, C Yurdaydın, G Kabacam, BA Ratsch, K Zachou, B Bremer, ... Hepatology 60 (1), 87-97, 2014 | 337 | 2014 |
| Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial H Wedemeyer, C Yurdaydin, S Hardtke, FA Caruntu, MG Curescu, ... The Lancet infectious diseases 19 (3), 275-286, 2019 | 192 | 2019 |
| Anti-HDV IgM as a marker of disease activity in hepatitis delta A Wranke, B Heidrich, S Ernst, B Calle Serrano, FA Caruntu, MG Curescu, ... PloS one 9 (7), e101002, 2014 | 86 | 2014 |
| Long Term Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Infection is Safe and Well Tolerated and Associated with Durable Virologic Response with no … P Marcellin, EJ Gane, R Flisiak, HN Trinh, J Petersen, S Gurel, KD Kaita, ... Hepatology 60, 313A-314A, 2014 | 85 | 2014 |
| Association between level of hepatitis D virus RNA at week 24 of pegylated interferon therapy and outcome O Keskin, H Wedemeyer, A Tüzün, K Zachou, X Deda, GN Dalekos, ... Clinical Gastroenterology and Hepatology 13 (13), 2342-2349. e2, 2015 | 81 | 2015 |
| Ten‐year follow‐up of a randomized controlled clinical trial in chronic hepatitis delta A Wranke, S Hardtke, B Heidrich, G Dalekos, K Yalçin, F Tabak, S Gürel, ... Journal of Viral Hepatitis 27 (12), 1359-1368, 2020 | 68 | 2020 |
| O4 prolonged therapy of hepatitis delta for 96 weeks with pegylated-interferon-α-2a plus tenofovir or placebo does not prevent HDVRNA relapse after treatment: the hidit-2 study H Wedemeyer, C Yurdaydin, S Ernst, FA Caruntu, MG Curescu, K Yalcin, ... Journal of Hepatology 1 (60), S2-S3, 2014 | 68* | 2014 |
| Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis? S Kaymakoǧlu, Y Çakaloǧlu, K Demir, S Türkoǧlu, S Badur, S Gürel, ... Journal of hepatology 28 (1), 78-83, 1998 | 65 | 1998 |
| Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study S Fung, P Kwan, M Fabri, A Horban, M Pelemis, HW Hann, S Gurel, ... Journal of Hepatology 66 (1), 11-18, 2017 | 59 | 2017 |
| The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer S Gürel, E Dolar, Ö Yerci, B Samli, H Öztürk, SG Nak, M Gülten, F Memik Journal of international medical research 27 (2), 74-78, 1999 | 58 | 1999 |
| High expression of multidrug resistance-1 (MDR-1) and its relationship with multiple prognostic factors in gastric carcinomas in patients in Turkey S Gürel, Ö Yerci, G Filiz, E Dolar, T Yilmazlar, SG Nak, M Gülten, ... Journal of international medical research 27 (2), 79-84, 1999 | 54 | 1999 |
| The relation between liver histopathology and GGT levels in viral hepatitis: more important in hepatitis B AT Eminler, K Irak, T Ayyıldız, M Keskin, M Kıyıcı, S Gürel, M Gülten, ... Aves, 2014 | 52 | 2014 |
| Evaluation of leukocyte esterase and nitrite strip tests to detect spontaneous bacterial peritonitis in cirrhotic patients S Torun, E Dolar, Y Yilmaz, M Keskin, M Kiyici, M Sinirtas, E Sarandol, ... World Journal of Gastroenterology: WJG 13 (45), 6027, 2007 | 41 | 2007 |
| Baseline and salt‐stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity M Keskin, E Dolar, M Dirican, M Kiyici, Y Yilmaz, S Gurel, SG Nak, ... Internal medicine journal 39 (4), 243-248, 2009 | 40 | 2009 |
| Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C. Y Yilmaz, E Dolar, E Ulukaya, S Akgoz, M Keskin, M Kiyici, O Yerci, ... Medical Science Monitor: International Medical Journal of Experimental and …, 2009 | 37 | 2009 |
| Residual low HDV viraemia is associated HDV RNA relapse after PEG‐IFNa‐based antiviral treatment of hepatitis delta: results from the HIDIT‐II study B Bremer, OE Anastasiou, S Hardtke, FA Caruntu, MG Curescu, K Yalcin, ... Liver International 41 (2), 295-299, 2021 | 34 | 2021 |
| After the eradication of Helicobacter pylori infection, relapse is a serious problem in Turkey S Gürel, F Besisk, K Demir, Z Mungan, S Kaymakoglu, G Boztas, ... Journal of clinical gastroenterology 28 (3), 241-244, 1999 | 34 | 1999 |
| A retrospective study demonstrating properties of nonvariceal upper gastrointestinal bleeding in Turkey S Bor, Ü Dağlı, B Sarer, N Tozun, B Sivri, T Akbaş, B Şahin, Y Batur Aves, 2011 | 32 | 2011 |
| Seven Years of Treatment with Tenofovir DF for Chronic Hepatitis B Virus Infection is Safe and Well Tolerated and Associated with Sustained Virological, Biochemical and … P Marcellin, EJ Gane, N Tsai, R Flisiak, J Petersen, S Gurel, IA Kotzev, ... Hepatology 58, 649A, 2013 | 31 | 2013 |
